SynopsisThis is a chemotherapy drug, often used in conjunction with other drugs, to treat a variety of cancers Global Vinblastine Sulfate market is projected to reach US$ 4785.6 million in 2029, increasing from US$ 2305 million in 2022, with the CAGR of 11.0% du.....
SynopsisDysplasia epiphysealis hemimelica (DEH), commonly known as Trevor disease, is a rare non-hereditary epiphyseal disorder, which is characterized by localized overgrowth of osteochondral affecting one or more ossification centers or epiphyses. The global D.....
SynopsisThe global Automated Fluorescence Microscope market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Automated Fluorescence Microscop.....
SynopsisA device for the oral treatment of children The global Ortho Pediatric Devices market was valued at US$ 4404.9 million in 2023 and is anticipated to reach US$ 6729.4 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030. A.....
SynopsisThe global Medical Grade Masks market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Medical Grade Masks volume and value at the global le.....
SynopsisThe global Vertebral Corpectomy Prostheses market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vertebral Corpectomy Prostheses in various end use industr.....
SynopsisThe global Topiramate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Topiramate in various end use industries. The expanding demands from the Tablet.....
SynopsisA medical device is any apparatus, appliance, software, material, or other article—whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for it.....
SynopsisOmalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to me.....
SynopsisThe global Low-density Lipoprotein Apheresis Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Low-density Lipoprotein .....
